Molecular dynamics simulation of amyloid β dimer formation

Biophysical Journal

Volumn 87, Issue 4, 2004, Pages 2310-2321

  Urbanc, B ^a   Cruz, L ^a   Ding, F ^a,b   Sammond, D ^b   Khare, S ^b   Buldyrev, S V ^a   Stanley, H E ^a   Dokholyan, N V ^b  

^a Boston University   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; WATER; MULTIPROTEIN COMPLEX;

ARTICLE; CONFORMATION; CONFORMATIONAL TRANSITION; DIMERIZATION; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; MOLECULAR MODEL; MOLECULAR STABILITY; OLIGOMERIZATION; PROTEIN STRUCTURE; THERMODYNAMICS; BINDING SITE; CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; COMPUTER SIMULATION; EVALUATION; MOTION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; VALIDATION STUDY;

AMYLOID BETA-PROTEIN; BINDING SITES; COMPUTER SIMULATION; DIMERIZATION; MODELS, CHEMICAL; MODELS, MOLECULAR; MOTION; MULTIPROTEIN COMPLEXES; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY;

EID: 10644242867     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1529/biophysj.104.040980     Document Type: Article

References (99)

1. Antzutkin, O. N., J. S. Balbach, and R. Tycko. 2003. Site-specific identification of non-beta-strand conformations in Alzheimer's β-amyloid fibrils by solid-state NMR. Biophys. J. 84:3326-3335.
2. Antzutkin, O. N., R. D. Leapman, J. J. Balbach, and R. Tycko. 2002. Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. Biochemistry. 41:15436-15450.
3. Balbach, J. J., A. T. Petkova, N. A. Oyler, O. N. Antzutkin, D. J. Gordon, S. C. Meredith, and R. Tycko. 2002. Supramolecular structure in full-length Alzheimer's β-amyloid fibrils: evidence for a parallel β-sheet organization from solid-state nuclear magnetic resonance. Biophys. J. 83:1205-1216.
4. Barrow, C. J., A. Yasuda, P. T. M. Kenny, and M. G. Zagorski. 1992. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. J. Mol. Biol. 225:1075-1093.
5. Barrow, C. J., and M. G. Zagorski. 1991. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. Science. 253:179-182.
6. Berendsen, H. J. C., J. P. M. Postma, W. F. van Gunsteren, A. Dinola, and J. R. Haak. 1984. Molecular-dynamics with coupling to an external bath. J. Chem. Phys. 81:3684-3690.
7. Berendsen, H. J. C., J. P. M. Postma, W. F. van Gunsteren, and J. Hermans. 1981. Interaction models for water in relation to protein hydration. In Intermolecular Forces. B. Pullman, editor. Reidel, Dordrecht, The Netherlands. 331-342.
8. Bitan, G., M. D. Kirkitadze, A. Lomakin, S. S. Vollers, G. B. Benedek, and D. B. Teplow. 2003a. Amyloid beta-protein (Ab) assembly: A beta 40 and A beta 42 oligomerize throuch distinct pathways. Proc. Natl. Acad. Sci. USA. 100:330-335.
9. Bitan, G., A. Lomakin, and D. B. Teplow. 2001. Amyloid-β-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 276:35176-35184.
10. 35 and amyloid beta-protein oligomerization. J. Am. Chem. Soc. 125:15359-15365.
11. Bitan, G., S. S. Vollers, and D. B. Teplow. 2003c. Elucidation of primary structure elements controlling early amyloid beta-protein oligomerization. J. Biol. Chem. 278:34882-34889.
12. Bonneau, R., and D. Baker. 2001. Ab initio protein structure prediction: progress and prospects. Annu. Rev. Biophys. Biomol. Struct. 30:173-189.
13. Borreguero, J. M., N. V. Dokholyan, S. V. Buldyrev, H. E. Stanley, and E. I. Shakhnovich. 2002. Thermodynamics and folding kinetic analysis of the SH3 domain from discrete molecular dynamics. J. Mol. Biol. 318:863-876.
14. Bucciantini, M., E. Giannoni, F. Chiti, F. Baroni, L. Formigli, J. Zurdo, N. Taddel, G. Ramponi, C. M. Dobson, and M. Stefani. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:507-511.
15. Chou, P. Y., and G. D. Fasman. 1974. Prediction of protein conformation. Biochemistry. 13:222-245.
16. Coles, M., W. Bicknell, A. A Watson, D. P. Fairlie, and D. J. Craik. 1998. Solution structure of amyloid-beta peptide (1-40) in a water-micelle environment: is the membrane spanning domain where we think it is? Biochemistry. 37:11064-11077.
17. Creighton, T. E. 1993. Proteins: Structures and Molecular Properties, 2nd ed. Freeman and Co., New York.
18. Crescenzi, O., S. Tomaselli, R. Guerrini, S. Salvatori, A. M. D'Ursi, P. A. Temussi, and D. Picone. 2002. Solution structure of the Alzheimer amyloid β-peptide (1-42) in an apolar microenvironment: similarity with a virus fusion domain. Eur. J. Biochem. 269:5642-5648.
19. Dahlgren, K. N., A. M. Manelli, W. Blaine Stine, Jr., L. K. Baker, G. A. Krafft, and M. J. LaDu. 2002. Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J. Biol. Chem. 277:32046-32053.
20. Darden, T., D. M. York, and L. G. Pedersen. 1993. Particle mesh Ewald: an N log(N) method for Ewald sums in large systems. J. Chem. Phys. 98:10089-10092.
21. Dill, K. A. 1999. Polymer principles and protein folding. Prot. Sci. 8:1166-1180.
22. Ding, F., J. M. Borreguero, S. V. Buldyrev, H. E. Stanley, and N. V. Dokholyan. 2003. A mechanism for the α-helix to β-hairpin transition. Proteins: Structure, Function, and Genetics. 53:220-228.
23. Ding, F., N. V. Dokholyan, S. V. Buldyrev, H. E. Stanley, and E. I. Shakhnovich. 2002a. Direct molecular dynamics observation of protein folding transition state ensemble. Biophys. J. 83:3525-3532.
24. Ding, F., N. V. Dokholyan, S. V. Buldyrev, H. E. Stanley, and E. I. Shakhnovich. 2002b. Molecular dynamics simulation of the SH3 domain aggregation suggests a generic amyloidogenesis mechanism. J. Mol. Biol. 324:851-857.
25. Dinner, A. R., S. S. So, and M. Karplus. 2002. Statistical analysis of protein folding kinetics. In Advances in Chemical Physics, Vol. 120. Computational Methods for Protein Folding. Richard A. Friesner, editor. Wiley Interscience, Chichester, UK. 1-34.
26. Dodart, J.-C., K. R. Bales, K. S. Gannon, S. J. Greene, R. B. DeMattos, C. Mathis, C. A. DeLong, S. Wu, W. Wu, D. M. Holtzman, and S. M. Paul. 2002. Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model. Nat. Neurosci. 5:452-457.
27. Dokholyan, N. V., S. V. Buldyrev, H. E. Stanley, and E. I. Shakhnovich. 1998. Molecular dynamics studies of folding of a protein-like model. Fold. Des. 3:577-587.
28. Durell, S. R., H. R. Guy, N. Arispe, E. Rojas, and H. B. Pollard. 1994. Theoretical models of the ion channel structure of amyloid β-protein. Biophys. J. 67:2137-2145.
29. El-Agnaf, O. M. A., D. S. Mahil, B. P. Patel, and B. M. Austen. 2000. Oligomerizalion and toxicity of β-amyloid-42 implicated in Alzheimer's disease. Biochem. Biophys. Res. Commun. 273:1003-1007.
30. El-Agnaf, O. M. A., S. Nagala, B. P. Patel, and B. M. Austen. 2001. Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils. J. Mol. Biol. 310:157-168.
31. Enya, M., M. Morishima-Kawashima, M. Yoshimura, Y. Shinkai, K. Kusui, K. Khan, D. Games, D. Schenk, S. Sugihara, H. Yamaguchi, and Y. Ihara. 1999. Appearance of sodium dodecyl sulfate-stable amyloid β-protein (Aβ) dimer in the cortex during aging. Am. J. Pathol. 154:271-279.
32. Ferro, D. R., J. E. McQueen, J. T. McCown, and J. Hermans. 1980. Energy minimization of rubredoxin. J. Mol. Biol. 136:1-18.
33. Fersht, A. R., and V. Daggett. 2002. Protein folding and unfolding at atomic resolution. Cell. 108:573-582.
34. Funato, H., M. Enya, M. Yoshimura, M. Morishima-Kawashima, and Y. Ihara. 1999. Presence of sodium dodecyl sulfate-stable amyloid β-protein dimers in the hippocampus CA1 not exhibiting neurofibrillary tangle formation. Am. J. Pathol. 155:23-28.
35. Garzon-Rodriguez, W., M. Sepulveda-Becerra, S. Milton, and C. G. Glabe. 1997. Soluble amyloid Aβ-(1-40) exists as a stable dimer at low concentrations. J. Biol. Chem. 272:21037-21044.
36. Golde, T. E., C. B. Eckman, and S. G. Younkin. 2000. Biochemical detection of A beta isoforms: implications for pathogenesis, diagnosis, and treatment of Alzheimer's disease. Biochem. Biophys. Acta. 1502:172-187.
37. Gravina, S. A., L. B. Ho, C. B. Eckman, K. E. Long, L. Otvos, Jr., L. H. Younkin, N. Suzuki, and S. G. Younkin. 1995. Amyloid beta protein (A beta) in Alzheimer's disease brain: biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J. Biol. Chem. 270:7013-7016.
38. 1-40 peptide in water: uncoupling β-structure folding from aggregation. Biochim. Biophys. Acta. 1476:93-102.
39. Hartley, D. M., D. M. Walsh, C. P. Ye, T. Diehl, S. Vasquez, P. M. Vassilev, D. B. Teplow, and D. J. Selkoe. 1999. Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19:8876-8884.
40. Hermans, J., H. J. C. Berendsen, W. F. van Gunsteren, and J. P. M. Postma. 1984. A consistent empirical potential for water-protein interactions. Biopolymers. 23:1513-1518.
41. Hermans, J., R. H. Yun, J. Leech, and D. Cavanaugh. 1994. Sigma documentation. University of North Carolina: http://hekto.med.unc.edu:8080/ HERMANS/software/SIGMA/index.html.
42. Hsia, A. Y., E. Masliah, L. McConlogue, G.-Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R. C. Malenka, R. A. Nicoll, and L. Mucke. 1999. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:3228-3233.
43. Huang, T. H. J., D.-S. Yang, N. P. Plaskos, S. Go, C. M. Yip, P. E. Fraser, and A. Chakrabartty. 2000. Structural studies of soluble oligomers of Alzheimer β-amyloid peptide. J. Mol. Biol. 297:73-87.
44. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graphics. 14.1:33-38.
45. Iwatsubo, T., A. Odaka, N. Suzuki, H. Mizusawa, N. Nukina, and Y. Ihara. 1994. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron. 13:45-53.
46. Karplus, M., and J. A. McCammon. 2002. Molecular dynamics simulations of biomolecules. Nat. Struct. Biol. 9:646-652.
47. Kayed, R., E. Head, J. L. Thompson, T. M. McIntire, S. C. Milton, C. W. Cotman, and C. G. Glabe. 2003. Common structure of soluble amyloid oligomers implies common mechanisms of pathogenesis. Science. 300:486-489.
48. Kirkitadze, M. D., G. Bitan, and D. B. Teplow. 2002. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies. J. Neurosci. Res. 69:567-577.
49. Kirkitadze, M. D., M. M. Condron, and D. B. Teplow. 2001. Identification and characterization of key kinetic intermediates in amyloid b-protein fibrillogenesis. J. Mol. Biol. 312:1103-1119.
50. Klein, W. L. 2002a. Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41:345-352.
51. Klein, W. L. 2002b. ADDLs and protofibrils - the missing link? Neurobiol. Aging. 23:231-233.
52. Klein, W. L., G. A. Krafft, and C. E. Finch. 2001. Targeting small A beta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24:219-224.
53. Kuo, Y.-M., M. R. Emmerling, C. Vigo-Pelfrey, T. C. Kasunic, J. B. Kirkpatrick, G. H. Murdoch, M. J. Ball, and A. E. Roher. 1996. Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271:4077-4081.
54. Kuo, Y.-M., S. Webster, M. R. Emmerling, N. De Lima, and A. E. Roher. 1998. Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A-β peptides of Alzheimer's disease. Biochim. Biophys. Acta. 1406:291-298.
55. Lambert, M. P., A. K. Barlow, B. A Chromy, C. Edwards, R. Freed, M. Liosatos, T. E. Morgan, I. Rozovsky, B. Trommer, K. L. Viola, P. Wals, C. Zhang, C. E. Finch, G. A. Krafft, and W. L. Klein. 1998. Diffusible, nonfibrillar ligands derived from Ab(1-42) are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci USA. 95:6448-6453.
56. Leach, A. R. 2001. Molecular Modelling: Principles and Applications, 2nd ed. Prentice-Hall, New York.
57. Levitt, M., M. Gerstein, E. Huang, S. Subbiah, and J. Tsai. 1997. Protein folding: the endgame. Annu. Rev. Biochem. 66:549-579.
58. 10-35): Sequence effects. Proc. Natl. Acad. Sci. USA. 99:14126-14131.
59. Malinchik, S. B., H. Inouye, K. E. Szumowski, and D. A. Kirschner. 1998. Structural analysis of Alzheimer's β(1-40) amyloid: protofilament assembly of tubular fibrils. Biophys. J. 74:537-545.
60. Mendes, J., R. Guerois, and L. Serrano. 2002. Energy estimation in protein design. Curr. Opin. Struct. Biol. 12:441-446.
61. Mirny, L., and E. I. Shakhnovich. 2001. Protein folding theory: from lattice to all-atom models. Annu. Rev. Biophphys. Biomol. Struct. 30:361-396.
62. Mucke, L., E. Masliah, G.-Q. Yu, M. Mallory, E. M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood, and L. McConlogue. 2000. High-level neuronal expression of Aβ-(1-42) in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20:4050-4058.
63. Nilsberth, C., A. Westlind-Danielsson, C. B. Eckman, M. M. Condron, K. Axelman, C. Forsell, C. Stenh, J. Luthman, D. B. Teplow, S. G. Younkin, J. Näslund, and L. Lannfelt. 2001. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat. Neurosci. 4:887-893.
64. Petkova, A. T., Y. Ishii, J. J. Balbach, O. N. Antzutkin, R. D. Leapman, F. Delaglio, and R. Tycko. 2002. A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl. Acad. Sci. USA. 99:16742-16747.
65. Plotkin, S. S., and J. N. Onuchic. 2002. Understanding protein folding with energy landscape theory, Part I: basic concepts. Q. Rev. Biophys. 35:111-167.
66. Podlisny, M. B., B. L. Ostaszewski, S. L. Squazzo, E. H. Koo, R. E. Rydell, D. B. Teplow, and D. J. Selkoe. 1995. Aggregation of secreted amyloid β-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J. Biol. Chem. 270:9564-9570.
67. Podlisny, M. B., D. M. Walsh, P. Amarante, B. L. Ostaszewski, E. R. Stimson, J. E. Maggio, D. B. Teplow, and D. J. Selkoe. 1998. Oligomerization of endogenous and synthetic amyloid β-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry. 37:3602-3611.
68. Rapaport, D. C. 1997. The Art of Molecular Dynamics Simulation. Cambridge University Press, Cambridge, UK.
69. Roher, A. E., M. O. Chaney, Y.-M. Kuo, S. D. Webster, W. B. Stine, L. J. Haverkamp, A. S. Woods, R. J. Cotter, J. M. Tuohy, G. A. Krafft, B. S. Bonnell, and M. R. Emmerling. 1996. Morphology and toxicity of Aβ dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271:20631-20635.
70. Scheuner, D., C. Eckman, M. Jensen, X. Song, M. Citron, N. Suzuki, T. D. Bird, J. Hardy, M. Hutton, W. Kukull, E. Larson, E. LevyLahad, M. Viitanen, E. Peskind, P. Poorkaj, G. Schellenberg, R. Tanzi, W. Wasco, L. Lannfelt, D. Selkoe, and S. Younkin. 1996. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med. 2:864-870.
71. Selkoe, D. J. 1997. Alzheimer's disease: genotypes, phenotypes and treatments. Science. 275:630-631.
72. Serpell, L. C., C. C. F. Blake, and P. E. Fraser. 2000. Molecular structure of a fibrillar Alzheimer's Aβ fragment. Biochemistry. 39:13269-13275.
73. Shen, C. L. S., and M. Murphy. 1995. Solvent effects on self-assembly of beta-amyloid peptide. Biophys. J. 69:640-651.
74. Smith, A. V., and C. K. Hall. 2001a. α-Helix formation: discontinuous molecular dynamics on an intermediate-resolution protein model. Proteins. 4:344-360.
75. Smith, A. V., and C. K. Hall. 2001b. Protein refolding versus aggregation: computer simulations on an intermediate-resolution protein model. J. Mol. Biol. 312:187-202.
76. Snow, C. D., N. Nguyen, V. S. Pande, and M. Gruebele. 2002. Absolute comparison of simulated and experimental protein-folding dynamics. Nature. 420:102-106.
77. Soreghan, B., J. Kosmoski, and C. Glabe. 1994. Surfactant properties of Alzheimer's Aβ peptides and the mechanism of amyloid aggregation. J. Biol. Chem. 269:28551-28554.
78. Suzuki, N., T. T. Cheung, X.-D. Cai, A. Odaka, L. Otvos, Jr., C. Eckman, T. E. Golde, and S. G. Younkin. 1994. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science. 264:1336-1340.
79. Takada, S., Z. Luthey-Schulten, and P. G. Wolynes. 1999. Folding dynamics with nonadditive forces: a simulation study of a designer helical protein and a random heteropolymer. J. Chem. Phys. 110:11616-11629.
80. Thirumalai, D., D. K. Klimov, and R. I. Dima. 2002. Insights into specific problems in protein folding using simple concepts. In Advances in Chemical Physics, Vol. 120. Computational Methods for Protein Folding. Richard A. Friesner, editor. Wiley Interscience, Chichester, UK. 35-76.
81. Thompson, L. K. 2003. Unraveling the secrets of Alzheimer's β-amyloid fibrils. Proc. Natl. Acad. Sci. USA. 100:383-385.
82. Tjernberg, L. O., D. J. E. Callaway, A. Tjernberg, S. Hahne, C. Lilliehöök, L. Terenius, J. Thyberg, and C. Nordstedt. 1999. A molecular model of Alzheimer amyloid β-peptide fibril formation. J. Biol. Chem. 274:12619-12625.
83. Tjernberg, L. O., A. Tjernberg, N. Bark, Y. Shi, B. P. Ruzsicska, Z. Bu, J. Thyberg, and D. J. E. Callaway. 2002. Assembling amyloid fibrils from designed structures containing a significant amyloid β-peptide fragment. Biochem. J. 366:343-351.
84. Török, M., S. Milton, R. Kayed, P. Wu, T. McIntire, C. G. Glabe, and R. Langen. 2002. Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277:40810-40815.
85. Vorobjev, Y. N., J. C. Almagro, and J. Hermans. 1998. Discrimination between native and intentionally misfolded conformations of proteins: ES/IS, a new method for calculating conformational free energy that uses both dynamics simulations with an explicit solvent and an implicit solvent continuum model. Proteins. 32:399-413.
86. Vorobjev, Y. N., and J. Hermans. 1999. ES/IS: estimation of conformational free energy by combining dynamics simulations with explicit solvent with an implicit solvent continuum model. Biophys. Chem. 78:195-205.
87. Vorobjev, Y. N., and J. Hermans. 2001. Free energies of protein decoys provide insight into determinants of protein stability. Protein Sci. 10:2498-2506.
88. Walsh, D. M., D. M. Hartley, Y. Kusumoto, Y. Fezoui, M. M. Condron, A. Lomakin, G. B. Benedek, D. J. Selkoe, and D. B. Teplow. 1999. Amyloid β-protein fibrillogenesis: structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274:25945-25952.
89. Walsh, D. M., I. Klyubin, J. V. Fadeeva, W. K. Cullen, R. Anwyl, M. S. Wolfe, M. J. Rowan, and D. J. Selkoe. 2002. Naturally secreted oligomers of amyloid b protein potently inhibit hippocampal long-term potentiation in vivo. Nature. 416:535-539.
90. Walsh, D. M., A. Lomakin, G. B. Benedek, M. M. Condron, and D. Teplow. 1997. Amyloid β-protein fibrillogenesis: detection of a protofibrillar intermediate. J. Biol. Chem. 272:22364-22372.
91. Weggen, S., J. L. Ericksen, P. Das, S. A. Sagi, R. Wang, C. U. Pietrzik, K. A. Findlay, T. W. Smith, M. P. Murphy, T. Butler, D. E. Kang, N. Marquez-Sterling, T. E. Golde, and E. H. Koo. 2001. A subset of NSAIDs lower amyloidogenic A beta 42 independently of cyclooxygenase activity. Nature. 414:212-216.
92. Westerman, M. A., D. Cooper-Blacketer, A. Mariash, L. Kotilinek, T. Kawarabayashi, L. H. Younkin, G. A. Carlson, S. G. Younkin, and K. H. Ashe. 2002. The relationship between Ab and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22:1858-1867.
93. Wolynes, P. G., Z. Luthey-Schulten, and J. N. Onuchic. 1996. Fast folding experiments and the topography of protein folding energy landscapes. Chem. Biol. 3:425-432.
94. Xia, W., J. Zhang, D. Kholodenko, M. Citron, M. B. Podlisny, D. B. Teplow, C. Haass, P. Seubert, E. H. Koo, and D. J. Selkoe. 1995. Enhanced production and oligomerization of the 42-residue amyloid β-protein by Chinese hampster ovary cells stably expressing mutant presinilins. J. Biol. Chem. 272:7977-7982.
95. Yankner, B. A. 1996. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16:921-932.
96. Yong, W., A. Lomakin, M. D. Kirkitadze, D. B. Teplow, S.-H. Chen, and G. B. Benedek. 2002. Structure determination of micelle-like intermediates in amyloid b-protein fibril assembly by using small angle neutron scattering. Proc. Natl. Acad. Sci. USA. 99:150-154.
97. Zagorski, M. G., and C. J. Barrow. 1992. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix - beta-sheet conversion for a homologous, 28-residue, N-terminal fragment. Biochemistry. 31:5621-5631.
98. Zagrovic, B., C. D. Snow, M. R. Shirts, and V. S. Pande. 2002. Simulation of folding of a small α-helical protein in atomistic detail using worldwide-distributed computing. J. Mol. Biol. 323:927-937.
99. Zhou, Y., and M. Karplus. 1997. Folding thermodynamics of a three-helix-bundle protein. Proc. Natl. Acad. Sci. USA. 94:14429-14432.